Robert Stirrups. Show Affiliations »
Abstract
Mesh: See more » Antigens, CD19/immunologyClinical Trials, Phase II as TopicDisease-Free SurvivalGenetic Therapy/adverse effectsGenetic Therapy/methodsHumansImmunotherapy, Adoptive/adverse effectsImmunotherapy, Adoptive/methodsLymphoma, Large B-Cell, Diffuse/geneticsLymphoma, Large B-Cell, Diffuse/immunologyLymphoma, Large B-Cell, Diffuse/mortalityLymphoma, Large B-Cell, Diffuse/therapyMulticenter Studies as TopicReceptors, Antigen, T-Cell/geneticsReceptors, Antigen, T-Cell/immunologyT-Lymphocytes/immunologyT-Lymphocytes/metabolismT-Lymphocytes/transplantationTreatment Outcome
Substances: See more » Antigens, CD19CD19 molecule, humanReceptors, Antigen, T-Cell
Year: 2017 PMID: 29249304 DOI: 10.1016/S1470-2045(17)30928-2
Source DB: PubMed Journal: Lancet Oncol ISSN: 1470-2045 Impact factor: 41.316